We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Data Bank for Eosinophilic Disorders

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00267475
First Posted: December 21, 2005
Last Update Posted: September 19, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Marc Rothenberg, Children's Hospital Medical Center, Cincinnati
  Purpose
The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders [EGID] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis [EE], eosinophilic colitis, and eosinophilic gastroenteritis [EGE]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.

Condition
Eosinophilic Esophagitis Gastritis Enteritis Eosinophilic Colitis Eosinophilic Gastroenteritis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)

Resource links provided by NLM:


Further study details as provided by Marc Rothenberg, Children's Hospital Medical Center, Cincinnati:

Estimated Enrollment: 500
Study Start Date: May 2001
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients diagnosed with an eosinophilic disorder and patients without an eosinophilic disorder to serve as normal controls
Criteria
Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00267475


Locations
United States, Ohio
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229-3039
Sponsors and Collaborators
Marc Rothenberg
Investigators
Principal Investigator: Marc E. Rothenberg, M.D., Ph.D. Children's Hospital Medical Center, Cincinnati
  More Information

Responsible Party: Marc Rothenberg, MD, PhD, Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier: NCT00267475     History of Changes
Other Study ID Numbers: 01-3-15
CSA1002171
First Submitted: December 15, 2005
First Posted: December 21, 2005
Last Update Posted: September 19, 2013
Last Verified: January 2013

Keywords provided by Marc Rothenberg, Children's Hospital Medical Center, Cincinnati:
eosinophilic esophagitis
eosinophilic gastritis
eosinophilic enteritis
eosinophilic colitis
eosinophilic gastroenteritis

Additional relevant MeSH terms:
Colitis
Esophagitis
Gastroenteritis
Eosinophilic Esophagitis
Gastritis
Enteritis
Eosinophilia
Gastrointestinal Diseases
Digestive System Diseases
Colonic Diseases
Intestinal Diseases
Esophageal Diseases
Leukocyte Disorders
Hematologic Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Stomach Diseases